We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current COCP market cap is 25.64M. The company's latest EPS is USD -1.7677 and P/E is -1.43.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.6M | 1M | 0 | 0 |
| Operating Income | -4.34M | -4.44M | -4.73M | -4.16M | -5.45M |
| Net Income | -4.17M | -4.17M | -4.46M | -3.96M | -5.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.56M | 2.01M | 0 | 0 | 2.6M |
| Operating Income | -48.41M | -9.59M | -14.22M | -19.74M | -18.56M |
| Net Income | -48.17M | -9.65M | -14.19M | -38.84M | -17.98M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.28M | 32.61M | 31.26M | 26.55M | 21.57M |
| Total Liabilities | 1.6M | 1.92M | 4.88M | 3.96M | 4.18M |
| Total Equity | 34.68M | 30.69M | 26.38M | 22.59M | 17.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.53M | 54.24M | 79.39M | 40.84M | 31.26M |
| Total Liabilities | 2.82M | 1.74M | 1.84M | 1.27M | 4.88M |
| Total Equity | 25.71M | 52.51M | 77.55M | 39.57M | 26.38M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.66M | -11.34M | -14.67M | -4.5M | -8.2M |
| Investing | -59k | -59k | -118k | -8k | -8k |
| Financing | 3.99M | 3.99M | 3.99M | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.56M | -9.83M | -12.72M | -21.44M | -14.67M |
| Investing | -145k | -240k | -52k | -74k | -118k |
| Financing | 6.42M | 35.66M | 38.47M | -27k | 3.99M |
| Market Cap | 25.64M |
| Price to Earnings Ratio | -1.43 |
| Price to Sales Ratio | 9.86 |
| Price to Cash Ratio | 0.97 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 10.17M |
| Average Volume (1 week) | 75.81k |
| Average Volume (1 Month) | 30.72k |
| 52 Week Change | 40.78% |
| 52 Week High | 3.10 |
| 52 Week Low | 1.325 |
| Spread (Intraday) | 0.28 (10.37%) |
| Company Name | Cocrystal Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cocrystalpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
